MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 527067 | Name: Lidocaine N-ethyl bromide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lidocaine N-ethyl bromide is a non-membrane-permeable blocker of fast Na+-dependent action potentials and voltage-dependent, non-inactivating Na+ conductance.

Chemical Structure

Lidocaine N-ethyl bromide
Lidocaine N-ethyl bromide
CAS#21306-56-9

Theoretical Analysis

MedKoo Cat#: 527067

Name: Lidocaine N-ethyl bromide

CAS#: 21306-56-9

Chemical Formula: C16H27BrN2O

Exact Mass: 342.1307

Molecular Weight: 343.31

Elemental Analysis: C, 55.98; H, 7.93; Br, 23.27; N, 8.16; O, 4.66

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Lidocaine N-ethyl bromide
IUPAC/Chemical Name
[2-(2,6-Dimethylanilino)-2-oxoethyl]-triethylazanium;bromide
InChi Key
DLHMKHREUTXMCH-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H26N2O.BrH/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5;/h9-11H,6-8,12H2,1-5H3;1H
SMILES Code
CC[N+](CC)(CC(NC1=C(C)C=CC=C1C)=O)CC.[Br-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 343.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Yin Q, Ke B, Chen X, Guan Y, Feng P, Chen G, Kang Y, Zhang W, Nie Y. Effects of Liposomes Charge on Extending Sciatic Nerve Blockade of N-ethyl Bromide of Lidocaine in Rats. Sci Rep. 2016 Dec 7;6:38582. doi: 10.1038/srep38582. PubMed PMID: 27924842; PubMed Central PMCID: PMC5141481. 2: Brenneis C, Kistner K, Puopolo M, Jo S, Roberson D, Sisignano M, Segal D, Cobos EJ, Wainger BJ, Labocha S, Ferreirós N, von Hehn C, Tran J, Geisslinger G, Reeh PW, Bean BP, Woolf CJ. Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block. Br J Pharmacol. 2014 Jan;171(2):438-51. doi: 10.1111/bph.12466. PubMed PMID: 24117225; PubMed Central PMCID: PMC3904263. 3: Roberson DP, Binshtok AM, Blasl F, Bean BP, Woolf CJ. Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review. Br J Pharmacol. 2011 Sep;164(1):48-58. doi: 10.1111/j.1476-5381.2011.01391.x. Review. PubMed PMID: 21457220; PubMed Central PMCID: PMC3171859. 4: Inan S, Dun NJ, Cowan A. Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence. Eur J Pharmacol. 2009 Aug 15;616(1-3):141-6. doi: 10.1016/j.ejphar.2009.06.026. Epub 2009 Jun 21. PubMed PMID: 19549515; PubMed Central PMCID: PMC2735214. 5: Bonjardim LR, da Silva AP, Gameiro GH, Tambeli CH, Ferraz de Arruda Veiga MC. Nociceptive behavior induced by mustard oil injection into the temporomandibular joint is blocked by a peripheral non-opioid analgesic and a central opioid analgesic. Pharmacol Biochem Behav. 2009 Jan;91(3):321-6. doi: 10.1016/j.pbb.2008.08.001. Epub 2008 Aug 8. PubMed PMID: 18755210. 6: Ting E, Roveroni RC, Ferrari LF, Lotufo CM, Veiga MC, Parada CA, Tambeli CH. Indirect mechanism of histamine-induced nociception in temporomandibular joint of rats. Life Sci. 2007 Aug 9;81(9):765-71. Epub 2007 Jul 26. PubMed PMID: 17706725. 7: Zelles T, Boyd JD, Hardy AB, Delaney KR. Branch-specific Ca2+ influx from Na+-dependent dendritic spikes in olfactory granule cells. J Neurosci. 2006 Jan 4;26(1):30-40. PubMed PMID: 16399670. 8: Dhingra NK, Freed MA, Smith RG. Voltage-gated sodium channels improve contrast sensitivity of a retinal ganglion cell. J Neurosci. 2005 Aug 31;25(35):8097-103. PubMed PMID: 16135767. 9: Oliveira MC, Parada CA, Veiga MC, Rodrigues LR, Barros SP, Tambeli CH. Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain. Eur J Pain. 2005 Feb;9(1):87-93. PubMed PMID: 15629879. 10: Laffon M, Jayr C, Barbry P, Wang Y, Folkesson HG, Pittet JF, Clerici C, Matthay MA. Lidocaine induces a reversible decrease in alveolar epithelial fluid clearance in rats. Anesthesiology. 2002 Feb;96(2):392-9. PubMed PMID: 11818773. 11: Roveroni RC, Parada CA, Cecília M, Veiga FA, Tambeli CH. Development of a behavioral model of TMJ pain in rats: the TMJ formalin test. Pain. 2001 Nov;94(2):185-91. PubMed PMID: 11690732. 12: Kilb W, Luhmann HJ. Characterization of a hyperpolarization-activated inward current in Cajal-Retzius cells in rat neonatal neocortex. J Neurophysiol. 2000 Sep;84(3):1681-91. PubMed PMID: 10980039. 13: Harsanyi K, Friedlander MJ. Transient synaptic potentiation in the visual cortex. II. Developmental regulation. J Neurophysiol. 1997 Mar;77(3):1284-93. PubMed PMID: 9084596. 14: Harsanyi K, Friedlander MJ. Transient synaptic potentiation in the visual cortex. I. Cellular mechanisms. J Neurophysiol. 1997 Mar;77(3):1269-83. PubMed PMID: 9084595. 15: Logan SD, Pickering AE, Gibson IC, Nolan MF, Spanswick D. Electrotonic coupling between rat sympathetic preganglionic neurones in vitro. J Physiol. 1996 Sep 1;495 ( Pt 2):491-502. PubMed PMID: 8887759; PubMed Central PMCID: PMC1160807. 16: Mangan PS, Lothman EW. Profound disturbances of pre- and postsynaptic GABAB-receptor-mediated processes in region CA1 in a chronic model of temporal lobe epilepsy. J Neurophysiol. 1996 Aug;76(2):1282-96. PubMed PMID: 8871236. 17: Peters BN, Masland RH. Responses to light of starburst amacrine cells. J Neurophysiol. 1996 Jan;75(1):469-80. PubMed PMID: 8822571. 18: Vautrin J, Schaffner AE, Barker JL. Fast presynaptic GABAA receptor-mediated Cl- conductance in cultured rat hippocampal neurones. J Physiol. 1994 Aug 15;479 ( Pt 1):53-63. PubMed PMID: 7990035; PubMed Central PMCID: PMC1155725. 19: Katchman AN, Vicini S, Hershkowitz N. Mechanism of early anoxia-induced suppression of the GABAA-mediated inhibitory postsynaptic current. J Neurophysiol. 1994 Mar;71(3):1128-38. PubMed PMID: 8201407. 20: Lambert NA, Wilson WA. Discrimination of post- and presynaptic GABAB receptor-mediated responses by tetrahydroaminoacridine in area CA3 of the rat hippocampus. J Neurophysiol. 1993 Feb;69(2):630-5. PubMed PMID: 8096243.